Details

Autor(en) / Beteiligte

• Murteira, Rodrigo
• Cary, Maria
• Galante, Heloísa
• Romano, Sónia
• Guerreiro, José Pedro
• Rodrigues, António Teixeira

Titel

Effectiveness of a collaborative diabetes screening campaign between community pharmacies and general practitioners

Ist Teil von

• Primary care diabetes, 2023-08, Vol.17 (4), p.314-320

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2023

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• To evaluate the impact of a collaborative screening campaign on the prevalence of pre-diabetes and diabetes among the screened population. A Longitudinal, multicentre study was developed. The Finnish Diabetes Risk Score (FINDRISC) was applied to the eligible population in the participating community pharmacies. Individuals with a FINDRISC score ≥ 15, were eligible to measure their glycated haemoglobin (HbA1c) level at the community pharmacy. If HbA1c≥ 5.7%, participants were referred to a general practitioner (GP) appointment for potential diagnosis of Diabetes. Out of 909 screened subjects, 405 (44.6%) presented a FINDRISC score ≥ 15. Among the latter, 94 (23.4%) had HbA1c levels that made them eligible for GP referral, of which 35 (37.2%) completed the scheduled appointments. 24 participants were diagnosed with pre-diabetes, and 11 with diabetes. The prevalence was estimated at 2.5% (CI95% 1.6–3.8%) and 7.8% (CI95% 6.2–9.8%) for diabetes and pre-diabetes, respectively. This collaborative model has proved to be effective in the early detection of diabetes and pre-diabetes. Joint initiatives between health professionals can play a pivotal role in the prevention and diagnosis of diabetes, which may lead to a reduction on the burden to health system and society. •45% of subjects screened had a high risk of developing diabetes in 10 years.•Over half of the subjects referred to the physician did not attend the appointment.•The prevalence of undiagnosed diabetes was estimated at 2.5% (CI95% 1.6–3.8%).